Verseon

Verseon Corporation is a technology-based pharmaceutical company focused on creating novel therapeutics for complex diseases. The company utilizes a proprietary computational platform to design and develop small-molecule drugs. Verseon's research and development efforts are concentrated on therapeutic areas including cardiovascular disease, cancer, diabetic macular edema (DME), and other ophthalmic conditions. The company's technology aims to improve drug efficacy and safety profiles by addressing the root causes of disease at the molecular level. Verseon operates on a global scale with research and development facilities located in the United States and Asia.